XML 71 R56.htm IDEA: XBRL DOCUMENT v3.8.0.1
Sales Of Business Components (Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 18, 2016
Feb. 03, 2016
Mar. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Proceeds from divestiture of business       $ 740,000 $ 19,795,000    
Payments to acquire distribution rights       $ 409,000 $ 1,226,000    
Geographic Concentration Risk [Member] | Long-Lived Assets [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Concentration percentage       99.00%      
Geographic Concentration Risk [Member] | Long-Lived Assets [Member] | Domestic [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Concentration percentage       60.00% 99.00%    
Hancock Jaffe [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Distribution agreement amount of payment             $ 3,400,000
Inventory received $ 1,700,000            
HeRO Graft Product Line [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Amount of consideration received from sale of product line   $ 18,500,000          
Proceeds from divestiture of business   17,800,000 $ 740,000        
Pre-tax gain (loss) on sale business components   $ 8,800,000          
ProCol [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Proceeds from divestiture of business 2,000,000            
Pre-tax gain (loss) on sale business components (845,000)            
Remaining prepayments settled $ 1,700,000            
HeRO Graft And ProCol Product Lines [Member] | Maximum [Member] | Product Lines Concentration Risk [Member] | Total Revenues [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Concentration percentage           10.00%  
HeRO Graft And ProCol Product Lines [Member] | Maximum [Member] | Product Lines Concentration Risk [Member] | Long-Lived Assets [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Concentration percentage           10.00%